Introduction
============

Pathogenic microbes and viruses, including those that cause AIDS, tuberculosis, and malaria, can remain closely associated with their hosts for decades. While much has been learned about microbial evolution from long-term *in vitro* experiments (reviewed in reference [@B1]), less is known about pathogen evolution during chronic infection. *Pseudomonas aeruginosa*, a ubiquitous Gram-negative bacterium, is a common cause of chronic illness in individuals with the heritable disease cystic fibrosis (CF), where it is the leading cause of morbidity and mortality ([@B2]). Upon infection, individuals with CF are unable to clear *P. aeruginosa* from the lungs, where it grows to high cell densities despite competing microorganisms, a strong host immune response, and antibiotic treatment ([@B2]). Several important features make *P. aeruginosa* CF lung infections suitable for studying microbial evolution *in vivo*. First, a single clone can colonize the lungs of a patient with CF for over a decade ([@B3]), enabling the study of chronological clonal isolates. In addition, much is known about the CF lung environment, including carbon source availability, oxygen content, and *in vivo* growth rates ([@B4]--[@B10]).

Previous studies have proposed that *P. aeruginosa* undergoes adaptive evolution in the CF lung primarily based on two observations. (i) There is a high ratio of nonsynonymous to synonymous mutations that occur over time ([@B11]). (ii) Isolates from chronic infections evolve similar phenotypes, including the following: formation of small colonies on agar (small colony variants or dwarf strains) ([@B12], [@B13]), overproduction of alginate exopolysaccharide (mucoid strains) ([@B12], [@B14]), quorum-sensing deficiency ([@B11], [@B15]), motility reduction ([@B16], [@B17]), altered lipopolysaccharide ([@B18]), reduced virulence factor expression ([@B19], [@B20]), and hypermutation ([@B21]). However, it is unclear how global changes in gene expression mediate these "CF-evolved" phenotypes.

Transcriptional profiling has been used to identify potential adaptive traits in two similarly grown *Escherichia coli* lineages after 20,000 generations ([@B22]). Based on these *in vitro* experiments, we hypothesized that transcriptional profiling would identify potential adaptive expression traits in *P. aeruginosa* lineages that evolved *in vivo*. As detailed analysis of gene expression profiling has not been performed on sequential *P. aeruginosa* strains obtained from multiple individuals with CF, we conducted transcriptomic analyses on 17 chronological clonal isolates collected over 3 months to 8 years from 3 CF patients. This reflects approximately 1,200 to 39,000 generations based on a previously estimated *P. aeruginosa* doubling time of 100 min in the CF lung ([@B10]). Our studies reveal that parallel changes in gene expression occur during *in vivo* evolution and that *P. aeruginosa* uses multiple pathways to establish chronic infection.

RESULTS {#h1}
=======

In order to identify gene expression changes that occur during chronic infection, transcriptional profiling was carried out on clonal *P. aeruginosa* isolates collected from 3 patients with CF ([Fig. 1](#f1){ref-type="fig"}). We anticipated that these analyses would reveal how different molecular processes are coordinated to establish long-term infection. Clonal isolates were collected between 3 months and 8 years after colonization. Individuals A, B, and C harbored unique *P. aeruginosa* clones (data not shown). A strain replacement occurred in individual C between 1983 and 1987, so these isolates are divided into clonal groups Ca and Cb.

![*Pseudomonas aeruginosa* isolates from three individuals with cystic fibrosis. Note that clonal groups Ca and Cb are isolated from the same individual, though they are different clonal groups (confirmed by RAPD assay and pulsed-field gel electrophoresis \[data not shown\]). More information is available in [Table S1](#ST1){ref-type="supplementary-material"} in the supplemental material. SCV, small colony variant.](mbo0041010390001){#f1}

Microarray analyses. {#h1.1}
--------------------

The Affymetrix *P. aeruginosa* GeneChip was designed from the *P. aeruginosa* PAO1 genome; therefore, it may be argued that the changes we observed reflect genetic variations between isolates rather than gene expression changes. However, a number of factors do not support this claim. First, the Affymetrix *P. aeruginosa* GeneChip is designed to capture genes using 13 unique 25-mer probes. Therefore, small variations (such as single-nucleotide polymorphisms) would not be significant after probe summarization. Second, we considered only genes that have orthologs in four other *P. aeruginosa* genomes (see Materials and Methods), so genes that are variable between *P. aeruginosa* strains were not included in our analyses. Third, the same microarray platform has been used successfully to assess the genomic content of various *P. aeruginosa* isolates, including environmental and CF isolates ([@B23]). Based on genomic DNA hybridization to the Affymetrix *P. aeruginosa* PAO1 GeneChip, it was reported that between 96.1% and 97.7% of the *P. aeruginosa* genome is conserved, including almost all known virulence factors ([@B23]). These data suggest that the Affymetrix *P. aeruginosa* PAO1 GeneChip is able to capture the conserved region of each gene in most *P. aeruginosa* strains. Finally, we analyzed our data using the Affymetrix MAS5 algorithm, which calls the presence or absence of target cDNAs based on the distribution of perfect match and mismatch probe signals. If our observations were derived from mutations that accumulated over time, we would have observed a high incidence of absence calls in the late strains compared to the early strains. However, as we report in [Table S6](#ST6){ref-type="supplementary-material"} in the supplemental material, we did not see this trend. These results clearly show that our observations reflect changes in gene expression rather than genetic variations.

Clonal isolates cluster by patient. {#h1.2}
-----------------------------------

To view the global features of our transcriptomic data, we first conducted hierarchical clustering of microarray signals obtained from each isolate. We used two similarity measures, Spearman correlation coefficient and Euclidean distance, to overcome the bias that can occur with one similarity measurement. Overall, transcriptomic clustering ([Fig. 2](#f2){ref-type="fig"}) clearly showed that isolates clustered by clonal group (*P* = 0.001 by analysis of similarity \[ANOSIM\]) rather than by morphological phenotype (*P* = 0.263 by ANOSIM) or time in the CF lung (*P* = 0.09 by ANOSIM). Similar results were obtained with both clustering methods. These data indicate that despite growth in the lungs for thousands of generations, *P. aeruginosa* isolates collected at later time points, at least in regard to gene expression, resemble the ancestor more than isolates from other individuals.

![Hierarchical clustering of microarray data. Normalized raw microarray signals of 5,391 genes (mean values for two biological replicates) were used for clustering. We confirmed that clusters of each clonal group are not dependent on the similarity measurement method by using both a Spearman correlation coefficient (A) and Euclidean distance (B).](mbo0041010390002){#f2}

Multiple solutions for establishing chronic infection exist. {#h1.3}
------------------------------------------------------------

Transcriptional profiling showed that clonal groups are highly similar, but there are some differences that account for each group clustering by patient. In order to identify these differences, we compared clonal groups (including ancestor strains) to each other. Clonal group A differentially expressed 65 genes, clonal group B differentially expressed 58 genes, clonal group Ca differentially expressed 119 genes, and clonal group Cb differentially expressed 99 genes (see [Table S4](#ST4){ref-type="supplementary-material"} in the supplemental material). A majority of these genes were involved in virulence, quorum sensing, alginate production, branched-chain amino acid metabolism, and motility ([Fig. 3](#f3){ref-type="fig"}; see [Table S4](#ST4){ref-type="supplementary-material"} in the supplemental material). These data suggest that in regard to gene expression, there are multiple solutions for establishing chronic infection in the lungs of patients with CF.

![Microarray heat maps of genes differentially expressed between clonal groups. Differentially expressed genes between clonal group A (A), clonal group B (B), clonal group Ca (C), and clonal group Cb (D) are shown. Each heat map shows a subset of differentially expressed genes between clonal groups with signals of \>1,000 in at least one strain. Comprehensive lists for these analyses are available in [Table S4](#ST4){ref-type="supplementary-material"} in the supplemental material. Red indicates high levels of mRNA, and blue indicates low levels of mRNA.](mbo0041010390003){#f3}

Ancestor strains are early colonizers of the CF lung. {#h1.4}
-----------------------------------------------------

To our knowledge, the ancestors were the first chronically established strains in each individual. However, these strains may have undergone adaptation before they were collected. In order to show that ancestral strains had not already undergone significant adaptation within the CF lung, we compared ancestor strains A1, B1, and Ca1 to the laboratory reference strain, PA14. PA14 was isolated from an acute burn wound; it has undergone minimal passage in the laboratory and maintains many of its original traits, making it a valuable non-CF reference strain. Ancestor strains A1, B1, and Ca1 differentially expressed 228, 181, and 265 genes, respectively, compared to strain PA14 (see [Table S5](#ST5){ref-type="supplementary-material"} in the supplemental material). In contrast, late isolates showed more than 600 gene expression changes compared to strain PA14. These results suggest that the ancestral strains show moderate gene expression changes compared to strain PA14, but since later isolates showed approximately 3-fold-more differences, the strains are still adapting to the CF lung. Strain Cb1 exhibited an adaptive phenotype, mucoidy, and is likely not the original ancestor of subsequent isolates, although this strain does display adaptation (see below).

Clonal groups exhibit parallel changes in gene expression. {#h1.5}
----------------------------------------------------------

We next examined gene expression changes within each lineage by comparing the transcriptomes of all isolates in each clonal group to their ancestor ([Fig. 4](#f4){ref-type="fig"}; see [Table S6](#ST6){ref-type="supplementary-material"} in the supplemental material). We focused on differentially expressed genes that were maintained throughout infection compared to each ancestor. Isolates in clonal group A differentially expressed 76 genes; these changes were maintained over 3 years. Four hundred forty-one changes were maintained over 8 years in isolates from clonal group B. Clonal group Ca differentially regulated 37 genes over 3 months, while clonal group Cb differentially regulated 281 genes over 7 years. These results indicate that 1 to 8% of *P. aeruginosa* genes displayed differences in expression after chronic infection within the CF lung.

![Microarray heat map of differentially expressed genes within clonal groups. All strains in each clonal group were compared to their ancestor (initial strain) and evaluated for significant changes in gene expression (\>2-fold change and FDR of \<0.05). The numbers used to generate this heat map are the mean fold changes (log~2~) in mRNA levels compared to the mRNA level of the ancestor strain of each clonal group. Red indicates an increase in the mRNA level, and blue indicates a decrease in the mRNA level. All genes detected in this analysis are reported separately in [Table S6](#ST6){ref-type="supplementary-material"} in the supplemental material.](mbo0041010390004){#f4}

Although the environment of the CF lung likely differs between individuals, we hypothesized that due to strong selective pressures in all patients (immune response, treatment, and consistent nutritional environment), *P. aeruginosa* isolates from different patients would display common changes in gene expression. To test this hypothesis, we compared the above within-group analyses and identified a set of genes that were commonly differentially expressed within all 3 lineages ([Table 1](#t1){ref-type="table"}). Clonal group Ca evolved over a short time period, 3 months; therefore, it was excluded from the analysis. Twenty-four genes commonly changed over time in clonal groups A, B, and Cb. Importantly, these genes changed in the same direction across all 3 lineages. Nine genes were downregulated, and 15 were upregulated. Four of the downregulated genes encoded proteins of unknown function, while the remaining were involved in type 4 fimbrial biogenesis. Ten genes encoding proteins of unknown function were upregulated. The other upregulated genes encode two outer membrane proteins (PA1048, OsmE), PA4880 (probable bacterioferritin), *phaF* (polyhydroxyalkanoate synthesis protein PhaF), and PA1562 (aconitase). Additionally, 86 genes were commonly regulated in at least 2 lineages ([Fig. 5](#f5){ref-type="fig"}; see [Table S6](#ST6){ref-type="supplementary-material"} in the supplemental material). Many of these genes were involved in flagellar biosynthesis, fimbrial (pilus) biosynthesis, and polyamine transport. The appearance of similar alterations in gene expression patterns, particularly changes in the same direction, suggests that *P. aeruginosa* undergoes parallel evolution in the CF lung.

![Common gene expression changes among three clonal groups. Venn diagram showing common changes in gene expression between three clonal groups (groups A, B, and Cb). The 24 genes commonly regulated in the three clonal groups are listed in [Table 1](#t1){ref-type="table"}. Genes that are positively regulated over time (+) and genes that are negatively regulated over time (-) are indicated (for instance, in the red circle at the top of the figure, of the 16 genes, 4 genes were positively regulated over time and 12 genes were negatively regulated over time.) The *P* value for the two clonal groups was calculated using a hypergeometric test and indicates that the probability of identifying the overlapping genes by random chance is very low. The full list of genes is available in [Table S6](#ST6){ref-type="supplementary-material"} in the supplemental material.](mbo0041010390005){#f5}

###### 

Genes exhibiting parallel expression changes in three clonal groups*^[a](#fnt1.1)^*

  Gene*[^b^](#fnt1.2)*   Annotation*[^b^](#fnt1.2)*                  Change in expression*[^c^](#fnt1.3)*
  ---------------------- ------------------------------------------- --------------------------------------
  PA0045                 Hypothetical protein                        Decrease
  PA0046                 Hypothetical protein                        Decrease
  PA0047                 Hypothetical protein                        Decrease
  PA0411 (*pilJ*)        Type 4 fimbrial biogenesis protein          Decrease
  PA5041 (*pilP*)        Type 4 fimbrial biogenesis protein          Decrease
  PA5042 (*pilO*)        Type 4 fimbrial biogenesis protein          Decrease
  PA5043 (*pilN*)        Type 4 fimbrial biogenesis protein          Decrease
  PA5044 (*pilM*)        Type 4 fimbrial biogenesis protein          Decrease
  PA5139                 Hypothetical protein                        Decrease
  PA1048                 Probable outer membrane protein precursor   Increase
  PA1106                 Hypothetical protein                        Increase
  PA1323                 Hypothetical protein                        Increase
  PA1324                 Hypothetical protein                        Increase
  PA1471                 Hypothetical protein                        Increase
  PA1562 (*acnA*)        Aconitase                                   Increase
  PA1592                 Hypothetical protein                        Increase
  PA2485                 Hypothetical protein                        Increase
  PA2779                 Hypothetical protein                        Increase
  PA3040                 Conserved hypothetical protein              Increase
  PA3691                 Hypothetical protein                        Increase
  PA4876 (*osmE*)        Osmotically inducible lipoprotein           Increase
  PA4880                 Probable bacterioferritin                   Increase
  PA5060 (*phaF*)        Polyhydroxyalkanoate synthesis protein      Increase
  PA5178                 Conserved hypothetical protein              Increase

 Only genes that have a \>2-fold change in mRNA levels compared to the mRNA level of each ancestor strain (FDR of \<0.05), changed in clonal groups A, B, and Cb, and maintained changes over time are listed. The raw data are available in [Table S6](#ST6){ref-type="supplementary-material"} in the supplemental material.

 Annotation data were downloaded from the Pseudomonas Genome Database on 23 November 2009.

 mRNA levels of the late strains were compared to those of the ancestor strain in each clonal group. "Increase" indicates that mRNA levels were higher in the late strains than in the ancestor strain, and "decrease" indicates that mRNA levels were lower in the late strains than in the ancestor strain.

DISCUSSION {#h2}
==========

Our goal was to identify adaptive expression traits of *P. aeruginosa* during chronic CF lung infection. Our study is limited by the absence of genetic data because we cannot correlate specific mutations with changes in gene expression, and pleiotropic effects cannot be ruled out. However, since genetic mutations can affect gene expression, our study is important for understanding the global evolution of *P. aeruginosa* during chronic infection. Our transcriptional analysis is the most comprehensive study of this type thus far. While D'Argenio et al. ([@B24]) and Hoboth et al. ([@B25]) compared transcriptional profiles of early and late isolates, these studies were limited by the number of samples or patients. In contrast, we characterized chronological, clonal isolates collected from multiple CF patients.

We identified 24 genes that showed similar changes in gene expression across 3 separate *P. aeruginosa* lineages. This is striking because our statistical analyses show that overlap between groups is highly significant (*P* value ≤10^−10^) ([Fig. 5](#f5){ref-type="fig"}), so the probability of identifying 24 genes by random chance is very low. Since patients with CF can carry diverse populations of *P. aeruginosa* at any given time, one obvious limitation to this study is sampling. However, all 3 late isolates recovered on the same date from patient B (B3.1, B3.2, and B3.3) showed 23 of 24 common gene expression changes, which strongly supports parallel evolution. Parallel evolution occurs when two closely related organisms independently develop the same adaptive traits due to the nature of their environments (reviewed in reference [@B26]). Parallelism is indicative of adaptive evolution, which has been proposed to occur in the CF lung ([@B11]). Our data are similar to those of Cooper et al. ([@B22]), who demonstrated that 2 independently evolving *E. coli* populations growing under similar laboratory conditions displayed the same 59 changes in gene expression after 20,000 generations. Later, Barrick et al. ([@B27]) showed that most of the 45 mutations occurring in this long-term evolution experiment were beneficial.

On the basis of these data, we hypothesize that some of the 24 commonly regulated genes encode adaptive traits ([Table 1](#t1){ref-type="table"}). There are several lines of evidence to support this claim. First, strong parallelism is a good indicator of adaptive evolution. Second, 5 fimbrial (pilus) biosynthetic genes (*pilJ*, *pilP*, *pilO*, *pilN*, and *pilM*) were downregulated over time in all 3 lineages ([Table 1](#t1){ref-type="table"}). It is well documented that the loss of pili protects *P. aeruginosa* from phagocytosis *in vivo* by neutrophils, thus allowing *P. aeruginosa* to escape a primary immune component in the lungs of patients with CF ([@B16], [@B28]--[@B30]). Third, 4 genes important for *P. aeruginosa* biofilm formation *in vitro* (PA5139, PA1592, PA2779, and PA4876) and 3 genes upregulated during biofilm growth *in vitro* (PA1471, PA4876, and PA1324) were differentially regulated over time in all 3 lineages ([@B31]--[@B33]). Resistance to antibiotics and to host clearance is partly attributed to *P. aeruginosa* biofilm growth in the CF lung ([@B34]--[@B36]), suggesting that adaptation to the biofilm lifestyle via differential expression of these genes is important for maintaining long-term infections. Finally, of the 24 genes, 3 (PA4876, PA1323, and PA1324) were upregulated in an important *P. aeruginosa* CF isolate, the Liverpool epidemic strain (LES), compared to laboratory strain PAO1 ([@B37]). LES is a particularly virulent *P. aeruginosa* CF strain; thus, expression of these traits may represent an important adaptation to the lung environment.

Our results indicate that parallel evolution occurs in the lungs of individuals with CF; however, our data also show that specific, within-lineage changes also occur. The contribution of parallel changes versus within-lineage changes is unclear. The number of traits identified as evolving in parallel ([@B24]) is smaller than the number of changes in gene expression within lineages (up to 441) and may represent only a core set of changes ([Fig. 5](#f5){ref-type="fig"}). For example, distinct virulence traits appear to be utilized by different clonal groups to establish and maintain infection, supporting previous hypotheses that *P. aeruginosa* employs unique evolutionary pathways to establish chronic infection ([@B38]) and that genes required for pathogenicity in one strain may not be required or predictive for others ([@B38]--[@B40]). Thus, we propose that natural selection may not be acting on individual virulence traits, but instead on some or all of the 24 genes identified in our study.

In microbes, parallel gene expression changes have been observed only in long-term *in vitro* evolution experiments. Our study shows parallel changes in gene expression of strains grown *in vivo* for up to 39,000 generations. It should be noted that we measured gene expression *in vitro*. While it is well documented that the medium used to grow bacteria in this study (synthetic cystic fibrosis sputum medium \[SCFM\]) closely mimics the nutritional environment of the CF lung ([@B7]), the number of traits undergoing parallel evolution may be underestimated, or some may be expressed only under our culture conditions. It would be ideal to sample *P. aeruginosa* RNA directly from sputum samples from patients with CF, but the extraction process is challenging and would likely reflect species heterogeneity. Finally, 19 genes (of 24) identified in this study represent traits that have not been previously identified as adaptive in the CF lung and are therefore temporal markers for *P. aeruginosa* chronic colonization. Many of these genes encode proteins of unknown function, suggesting that future studies aimed at understanding the roles of these genes could provide unique insight into selective pressures in the CF lung.

MATERIALS AND METHODS {#h3}
=====================

Isolate collection and genetic analyses. {#h3.6}
----------------------------------------

Clonal isolates of *P. aeruginosa* were collected and clonally purified from three patients with CF at the British Columbia's Children's Hospital, Shaughnessy Hospital, or St. Paul's Hospital (all three hospitals are located in Vancouver, British Columbia, Canada) as previously described ([@B16]). Briefly, *P. aeruginosa* was isolated from sputum or throat samples and plated on Columbia agar supplemented with 5% sheep blood, MacConkey agar, or chocolate agar. On the basis of morphology, isolates were characterized as classic (C), dwarf (D), or mucoid (M) ([@B12]). Isolates A1, B1, and Ca2 were collected from respiratory sites, and the remaining isolates were collected from the throat or sputum ([Fig. 1](#f1){ref-type="fig"}; see [Table S1](#ST1){ref-type="supplementary-material"} in the supplemental material). The isolates were subcultured on Columbia blood agar, resuspended in 2 ml Mueller-Hinton broth with 8% dimethyl sulfoxide (DMSO), and stored at −75°C. To confirm that the isolates were *P. aeruginosa*, they were plated on a selective medium, FC agar ([@B41]). Genomic DNA extraction and genetic typing were carried out as previously described ([@B3]). *P. aeruginosa* isolates were typed by randomly amplified polymorphic DNA (RAPD) typing using primer 272 ([@B3]). All isolates from each individual are clonal except for patient C; a strain replacement occurred in patient C between 1983 and 1987 ([Fig. 1](#f1){ref-type="fig"}; see [Table S1](#ST1){ref-type="supplementary-material"} in the supplemental material). For clarity, clonal isolates from individuals A, B, and C will be referred to as clonal groups A, B, Ca, and Cb. Isolates collected from patient C are split into 2 clonal groups, Ca and Cb, due to the aforementioned strain replacement. Chronological isolates from each clonal set are designated by the patient letter (A, B, Ca, and Cb) along with the temporal order of isolation. For example, A1 was the first isolate collected from individual A, A2 was the second isolate, and A3.1 and A3.2 were isolated on the same date but displayed different morphologies ([Fig. 1](#f1){ref-type="fig"}; see [Table S1](#ST1){ref-type="supplementary-material"} in the supplemental material).

*P. aeruginosa* annotation. {#h3.7}
---------------------------

All analyses were based on the *P. aeruginosa* PAO1 annotation (downloaded from the Pseudomonas Genome Database on 23 November 2009). To exclude PAO1 strain-specific genes, we defined a conserved gene set using 4 *P. aeruginosa* genomes maintained at PseudoCAP (PAO1, PA14, PA7, and LESB58) based on the reciprocal best-hit BLAST method. We identified 5,465 PAO1 genes (out of 5,569 PAO1 genes; 4,699 genes were conserved among all 4 strains) that have at least one ortholog in the other 3 strains; these genes were considered for further analysis (see [Table S2](#ST2){ref-type="supplementary-material"} in the supplemental material). To assign microarray probe sets to these genes, we downloaded probe sequences from the Affymetrix website (Affymetrix, Santa Clara, CA) and mapped them to the *P. aeruginosa* PAO1 genome (GenBank accession no. NC002516.2) by using Exonerate (version 2.20) ([@B42]). After discarding probes that were not uniquely mapped on the genome, we mapped them again to *P. aeruginosa* PAO1 cDNA sequences. If less than 12 probes or more than 14 probes in a probe set were mapped to a gene, it was discarded, since each gene was represented by 13 unique probes. Thus, a total of 5,391 coding genes were considered in microarray data analysis (see [Table S3](#ST3){ref-type="supplementary-material"} in the supplemental material).

Expression profiling with Affymetrix microarrays. {#h3.8}
-------------------------------------------------

Microarray analyses were performed in duplicate on clonal isolates from 3 different individuals with CF. These analyses included the following strains: A1, A2, A3.1, A3.2, A4 (A strains from individual A), B1, B2.1, B2.2, B2.3, B3.1, B3.2, B3.3 (B strains from individual B), Ca1, Ca2, Cb1, Cb2, Cb3 (Ca and Cb strains from individual C), UCBPP-PA14 (PA14), and PAO1. Clinical isolates and the reference strains PA14 and PAO1 ([@B6]) were routinely grown on Difco blood agar base (BD Sciences) supplemented with 5% sheep blood (Remel) or brain heart infusion agar (Fisher). All Affymetrix GeneChip experiments were performed in synthetic cystic fibrosis sputum medium (SCFM), which mimics the nutritional environment of the CF lung ([@B7]). Bacterial growth in liquid medium (25 ml in a 250-ml flask) was monitored by measuring the optical density at 600 nm (OD~600~) during growth at 37°C with shaking at 250 rpm.

Global gene expression profiling was carried out as previously described ([@B6], [@B43]) with minor modifications. *P. aeruginosa* isolates were grown in SCFM, and the cells were harvested during exponential phase (OD~600~ of 0.4 to 0.5). Cultures were mixed 1:1 with RNAlater (Ambion), an RNA-stabilizing agent. RNA was isolated using the RNeasy minikit (Qiagen), and cDNA was prepared for Affymetrix GeneChip microarray analysis as previously described ([@B6], [@B43]). PCR amplification of the *P. aeruginosa rplU* gene ([@B44], [@B45]) was used to detect DNA contamination using the primers rplU-For (named For for forward primer) (5′-CGCAGTGATTGTTACCGGTG-3′) and rplU-Rev (named Rev for reverse primer) (5′-AGGCCTGAATGCCGGTGATC-3′). To assess RNA integrity, the samples were subjected to agarose gel electrophoresis. Affymetrix GeneChips were washed, stained, and scanned using an Affymetrix fluidics station at the University of Iowa DNA core facility.

Microarray analyses. {#h3.9}
--------------------

We preprocessed microarray .CEL files by the RMA (robust multiarray analysis) method by using the *affy* package (version 1.18.2) ([@B46]) in R (version 2.8.1) with default options (correction with perfect match probes only, quantile normalization, and expression measure by median polish). Hierarchical clustering analysis was performed with these signals after summarizing two signals from biological replicates by their mean and tested by both Euclidean distance and Spearman correlation coefficient as similarity measures.

Gene expression differences were evaluated by a linear model, implemented on the *limma* package in R (version 2.16.5) ([@B47]). If the maximum signal of the probe set among all isolates was less than 100, it was not considered in the analysis. We considered genes to be significantly differentially expressed if they changed \>2-fold and the false discovery rate (FDR) was less than 0.05. Differentially expressed genes between clonal groups (see [Table S4](#ST4){ref-type="supplementary-material"} in the supplemental material) were identified by the following 2 steps. (i) We compared the expression levels of all isolates in the same clonal group to those in another clonal group. (ii) We identified differentially expressed genes between two groups based on an FDR of \<0.05 and a \>2.0-fold change. Differentially expressed genes over time within clonal groups (see [Table S6](#ST6){ref-type="supplementary-material"} in the supplemental material) were identified by the following five steps or criteria. (i) We compared the gene expression levels of all isolates from each clonal group to the ancestor. (ii) We identified differentially expressed genes based on an FDR of \<0.05 and a \>2.0-fold change. (iii) We discarded genes that changed in the direction opposite the direction of the ancestor (i.e., upregulated in the intermediate isolate and downregulated in the late isolate). (iv) If the level of gene expression was significantly different in any isolate within the same group, it was selected. (v) If a gene was expressed differently in both the intermediate and late isolates, it was selected. ANOSIM test was conducted by using the vegan (<http://vegan.r-forge.r-project.org/>) package in R ([@B48]).

Microarray data accession number. {#h3.10}
---------------------------------

All microarray data are available at the NCBI GEO database (accession no. GSE21966). Supplemental material is also available on the World Wide Web at http://www.marcottelab.org/index.php/PSEAE_CF.2010.
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